Although several studies have confirmed that the alteration involving chromosome 12 leads to the overexpression of HMGA2 in patients with MPN [122,135], data from the work by Chen et al. demonstrated that the regulation of let-7a miRNA has a very important impact on the expression of HMGA2 in patients with MPN. This evidence concerns the gene HMGA2 and myeloproliferative neoplasm.